Abstract |
The 25-methoxy hispidol A (25-MHA) is a triterpenoid, isolated from the immature fruit of Poncirus trifoliata (Rutaceae). The pretreatment with 25-MHA markedly (p < 0.001) attenuated the formalin-induced biphasic responses as well as acetic acid-induced writhing responses. The intraperitoneal administration of 25-MHA significantly attenuated the mechanical hyperalgesia (p < 0.001) and allodynia (p < 0.05). Similarly, 25-MHA also significantly attenuated (p < 0.001) complete Freund's adjuvant (CFA)-induced paw edema in mice. The 25-MHA treatment significantly attenuated the production of nuclear kappa B (NF-κB) (p65 nuclear subunit). The cytokines are the important mediators of inflammation and pain; however, treatment with 25-MHA exhibited significant inhibition (p < 0.001) on the mRNA expression levels of various inflammatory mediators. The 25-MHA administration also significantly enhanced antioxidant enzymes (p < 0.001) and inhibited the oxidative stress markers. The current study indicates that 25-MHA significantly (p < 0.001) inhibited the nitric oxide (NO) in mice plasma. Similarly, the haematoxylin and eosin (H&E) staining shows that 25-MHA administration significantly inhibited the inflammatory process in the mice paw tissue compared with the CFA-treated group. The 25-MHA treatment did not exhibited any toxicity on the liver, kidney, muscles strength, and motor co-ordination in mice. The 25-MHA was coadministered with the various drugs such as tramadol, piroxicam, and gabapentin to observe the synergistic effect.
|
Authors | Ashrafullah Khan, Muhammad Zia Ullah, Ruqayya Afridi, Hina Rasheed, Sidra Khalid, Hadayat Ullah, Hussain Ali, Shakir D AlSharari, Yeong Shik Kim, Salman Khan |
Journal | Phytotherapy research : PTR
(Phytother Res)
Vol. 33
Issue 2
Pg. 327-341
(Feb 2019)
ISSN: 1099-1573 [Electronic] England |
PMID | 30456885
(Publication Type: Journal Article)
|
Copyright | © 2018 John Wiley & Sons, Ltd. |
Chemical References |
- 25-methoxyhispidol A
- Analgesics
- NF-kappa B
- Triterpenes
- Nitric Oxide
- Carrageenan
- Freund's Adjuvant
- Nitric Oxide Synthase Type II
|
Topics |
- Analgesics
(pharmacology, therapeutic use)
- Animals
- Carrageenan
- Down-Regulation
(drug effects)
- Edema
(chemically induced, drug therapy)
- Freund's Adjuvant
- Hyperalgesia
(chemically induced, drug therapy, metabolism)
- Inflammation
(drug therapy, metabolism)
- Male
- Mice
- NF-kappa B
(metabolism)
- Nitric Oxide
(metabolism)
- Nitric Oxide Synthase Type II
(metabolism)
- Pain
(chemically induced, drug therapy, metabolism)
- Poncirus
(chemistry)
- Rutaceae
(chemistry)
- Signal Transduction
(drug effects)
- Triterpenes
(pharmacology, therapeutic use)
|